Invexans Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Nicolas Concha Rosales
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 6.8yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 16yrs |
Recent management updates
Recent updates
Invexans (SNSE:INVEXANS) Is Looking To Continue Growing Its Returns On Capital
Sep 23
The Return Trends At Invexans (SNSE:INVEXANS) Look Promising
Apr 29Invexans (SNSE:INVEXANS) Is Doing The Right Things To Multiply Its Share Price
Aug 27Here's Why Invexans (SNSE:INVEXANS) Can Manage Its Debt Responsibly
Oct 30We Think Invexans (SNSE:INVEXANS) Is Taking Some Risk With Its Debt
May 06Invexans (SNSE:INVEXANS) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Apr 01Returns On Capital Are Showing Encouraging Signs At Invexans (SNSE:INVEXANS)
Mar 30Introducing Invexans (SNSE:INVEXANS), The Stock That Zoomed 155% In The Last Year
Feb 16
Would Invexans (SNSE:INVEXANS) Be Better Off With Less Debt?
Dec 23CEO
Nicolas Concha Rosales
6.8yrs
Tenure
Nicolas Concha Rosales has been Chief Executive Officer of Invexans S.A. since February 1, 2017.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 16.4yrs | US$46.48k | no data | |
| Director | 43.8yrs | US$4.79k | no data | |
| Director | 29.8yrs | US$37.51k | no data | |
| Board Advisor | no data | no data | no data | |
| Director | 15.7yrs | US$55.87k | no data | |
| Director | 4.7yrs | no data | no data | |
| Director | no data | no data | no data | |
| Vice Chairman of the Board | 1.6yrs | no data | no data |
16.0yrs
Average Tenure
61yo
Average Age
Experienced Board: INVEXANS's board of directors are seasoned and experienced ( 16 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/11/23 14:47 |
| End of Day Share Price | 2023/11/21 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Invexans S.A. is covered by 1 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Santander |